spacer
home > ebr > spring 2017 > managing e&l unknown compounds
PUBLICATIONS
European Biopharmaceutical Review

Managing E&L Unknown Compounds

Unknown compound characterisation has always been one of the most challenging aspects of analytical chemistry. Despite the difficulties, this identification is critical for a meaningful extractables and leachables (E&L) evaluation of container closure systems; single-use systems; drug delivery and combination products; and medical devices.

Identification of unknown extractable compounds is key to a successful E&L study due to the fact that there is no universally established concentration limit for leachable compounds. As a result, a toxicological risk assessment based on the intended dosing regimen of the product is required to determine if a potential leachable compound poses a risk to patient safety. Unfortunately, accurate and meaningful toxicological assessments are not possible for unknown compounds. These are typically assessed using a worst case scenario, where they are evaluated as extremely toxic – this however often leads to applying an inaccurate level of risk. Therefore, a systematic approach for the characterisation of unknown extractable compounds is essential to enable scientists to assign the correct degree of toxicological concern to a given analyte.

So, how does one go about identifying an unknown compound? The use of the proper instrumentation is critical. High resolution mass spectrometers that enable an accurate mass determination to at least three decimal places – such as liquid chromatographyquadrupole time of flights (LC-QTOFs) and gas chromatography (GC)-QTOFs – are suitable for this purpose and their use generates a plethora of data that can often lead to the identification of an empirical formula or class of compound for the unknown. This information can then be further evaluated with specialised software that is able to quickly search historical data and databases to provide a preliminary identification of the unknown extractable compound.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Simone Carrara, E&L Laboratory Manager; Andrew Blakinger, Manager, Extractables & Leachables Testing; Thomas Lehman, PhD, Director, Method Development and Validation and Extractables and Leachables, Eurofins BioPharma Product Testing
spacer
Simone Carrara
spacer
spacer
spacer
Andrew Blakinger
spacer
spacer
spacer
Thomas Lehman
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Dempsey Demystifies Regulatory Cycle at DIA Europe

March 22, 2018 (Hartford, Conn.) – RWS Life Sciences Managing Director, Sheena Dempsey, will present “Demystifying the Multilingual Complexities in the Regulatory Cycle” at DIA Europe 2018, on April 17, at 3:30PM (CET), in Basel, Switzerland.
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

 
Industry Events

On Helix 2018

10-11 July 2018, The Cambridge Building, Babraham Research Campus

ON Helix is a two-day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement